Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Net Margin (2018 - 2025)

Historic Net Margin for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to 41.1%.

  • Exagen's Net Margin fell 9000.0% to 41.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.94%, marking a year-over-year increase of 3700.0%. This contributed to the annual value of 27.17% for FY2024, which is 179200.0% up from last year.
  • Latest data reveals that Exagen reported Net Margin of 41.1% as of Q3 2025, which was down 9000.0% from 25.81% recorded in Q2 2025.
  • Over the past 5 years, Exagen's Net Margin peaked at 19.69% during Q2 2024, and registered a low of 192.87% during Q2 2022.
  • In the last 5 years, Exagen's Net Margin had a median value of 41.1% in 2025 and averaged 56.64%.
  • Per our database at Business Quant, Exagen's Net Margin plummeted by -1426900bps in 2022 and then soared by 1574100bps in 2023.
  • Over the past 5 years, Exagen's Net Margin (Quarter) stood at 55.58% in 2021, then plummeted by -112bps to 117.76% in 2022, then surged by 66bps to 40.25% in 2023, then surged by 32bps to 27.54% in 2024, then plummeted by -49bps to 41.1% in 2025.
  • Its last three reported values are 41.1% in Q3 2025, 25.81% for Q2 2025, and 24.21% during Q1 2025.